The Bovespa Index is down 173.29 points or 0.12% today to 141618.29 --Down 1021.85 points or 0.72% over the last two trading days ...

Wholesale inflation data Wednesday and consumer inflation data Thursday are the last major economic signals ahead of the Federal Reserve meeting next week. Preliminary revisions to 2024-25 jobs data ...

The Federal Communications Commission is ending its investigation into whether EchoStar was sufficiently utilizing its spectrum licenses after the company agreed to sell some of its spectrum to SpaceX ...

Apple shares ticked down after the unveiling of the tech giant's iPhone Air, a lighter version of the world's best-selling smart-phone, failed to live up to the company's preview hype about upgrades ...

Dollar/Canadian dollar: 1.3844 Canadian dollars per dollar (0.7224 dollar per Canadian dollar) --Today the dollar gained 0.29% vs. the Canadian dollar ...

Although it has been outperforming many peers over the past few years in a challenging environment, we believe Urban Outfitters lacks a brand intangible asset that would provide an economic moat and ...

Shares of Oracle surged 26% in the extended session Tuesday. If that gain holds through Wednesday's close, it would mark the stock's best performance since June 1999, according to FactSet. "It was an ...

Dow Jones Top Markets Headlines at 5 PM ET: All Three Major Stock-Market Indexes Close at Records on Hopes for Deeper Rate Cuts | Inflation ... All Three Major Stock-Market Indexes Close at Records on ...

GameStop earned $168.6 million, or 31 cents a share, in the quarter, up from $14.8 million, or 4 cents a share, in the prior year's quarter and marking a fifth straight quarterly profit. On an ...

Johnson & Johnson received Food and Drug Administration approval for Inlexzo, a treatment for people with bladder cancer.

Stripping out one-time items, adjusted earnings were $1.47 a share. Analysts polled by FactSet had been expecting $1.48 a share. Revenue climbed 12% to $14.93 billion, shy of analyst targets for ...